These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25977576)

  • 21. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
    Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.
    Ho AJ; Hua X; Lee S; Leow AD; Yanovsky I; Gutman B; Dinov ID; Leporé N; Stein JL; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2010 Apr; 31(4):499-514. PubMed ID: 19780044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of apparent diffusion coefficient mappings in amnestic mild cognitive impairment using an image analysis software brain search.
    Zhang B; Zhang JG; Zhao H; Zhang X; Li M; Qian L; Wang K; Tian CS; Guo WH; Cao QY; Zhou ZY; Yu H; Li C; Xu J; Cao W; Zhu B; Xu Y
    Acta Radiol; 2011 Dec; 52(10):1147-54. PubMed ID: 21969707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging reveals visual pathway damage in patients with mild cognitive impairment and Alzheimer's disease.
    Nishioka C; Poh C; Sun SW
    J Alzheimers Dis; 2015; 45(1):97-107. PubMed ID: 25537012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.
    Radanovic M; Pereira FR; Stella F; Aprahamian I; Ferreira LK; Forlenza OV; Busatto GF
    Expert Rev Neurother; 2013 May; 13(5):483-93. PubMed ID: 23621306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer's disease and mild cognitive impairment.
    O'Dwyer L; Lamberton F; Bokde AL; Ewers M; Faluyi YO; Tanner C; Mazoyer B; O'Neill D; Bartley M; Collins DR; Coughlan T; Prvulovic D; Hampel H
    J Alzheimers Dis; 2011; 26(4):667-82. PubMed ID: 21694456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
    Hua X; Hibar DP; Ching CR; Boyle CP; Rajagopalan P; Gutman BA; Leow AD; Toga AW; Jack CR; Harvey D; Weiner MW; Thompson PM;
    Neuroimage; 2013 Feb; 66():648-61. PubMed ID: 23153970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    Eustache P; Nemmi F; Saint-Aubert L; Pariente J; Péran P
    J Alzheimers Dis; 2016; 50(4):1035-50. PubMed ID: 26836151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
    Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
    Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voxel-wise co-analysis of macro- and microstructural brain alteration in mild cognitive impairment and Alzheimer's disease using anatomical and diffusion MRI.
    Cardenas VA; Tosun D; Chao LL; Fletcher PT; Joshi S; Weiner MW; Schuff N
    J Neuroimaging; 2014; 24(5):435-43. PubMed ID: 23421601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion?
    van Bruggen T; Stieltjes B; Thomann PA; Parzer P; Meinzer HP; Fritzsche KH
    Psychiatry Res; 2012; 203(2-3):184-93. PubMed ID: 22947309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients.
    Scrascia F; Curcio G; Ursini F; Trotta L; Quintiliani L; Migliore S; Altamura C; Pitocco F; Altavilla R; Melgari JM; Quattrocchi CC; Vernieri F
    J Alzheimers Dis; 2014; 38(4):939-50. PubMed ID: 24121958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment.
    Binnewijzend MA; Schoonheim MM; Sanz-Arigita E; Wink AM; van der Flier WM; Tolboom N; Adriaanse SM; Damoiseaux JS; Scheltens P; van Berckel BN; Barkhof F
    Neurobiol Aging; 2012 Sep; 33(9):2018-28. PubMed ID: 21862179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.